ALL vs IBO · P/E 4.9, $56.89B cap vs rev $18.0K
The Allstate Corporation (ALL) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. IBO currently screens at market cap $7.6M.
Not investment advice. Open the ALL and IBO stock pages for the full models.
Not investment advice.